Biomark Diagnostics Inc. (FRA:20B)
Germany
· Delayed Price · Currency is EUR 0.278
+0.012 (4.51%)
Last updated: Dec 4, 2025, 3:43 PM CET
Biomark Diagnostics Revenue
Biomark Diagnostics had revenue of 6.87K CAD in the quarter ending September 30, 2025, a decrease of -82.08%. This brings the company's revenue in the last twelve months to 123.42K, down -21.89% year-over-year. In the fiscal year ending March 31, 2025, Biomark Diagnostics had annual revenue of 154.22K, down -5.52%.
Revenue (ttm)
123.42K CAD
Revenue Growth
-21.89%
P/S Ratio
381.29
Revenue / Employee
n/a
Employees
n/a
Market Cap
28.79M EUR
Revenue Chart
* This company reports financials in CAD.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Rheinmetall AG | 11.00B |
| Deutsche Bank Aktiengesellschaft | 29.86B |